1. Search Result
Search Result
Results for "

ionizable amino lipid

" in MedChemExpress (MCE) Product Catalog:

24

Inhibitors & Agonists

12

Biochemical Assay Reagents

14

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-150118

    Liposome Others
    Lipid 8 is an ionizable amino lipid that can be used to synthesize lipid nanoparticles (LNPs). Lipid 8 is applicable to research in drug delivery .
    Lipid 8
  • HY-150115

    Liposome Others
    Lipid 10 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 10
  • HY-150117

    Liposome Others
    Lipid 6 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 6
  • HY-153378

    Liposome Others
    Lipid 15 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 15
  • HY-150116

    Liposome Others
    Lipid 1 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 1
  • HY-148648

    Liposome Others
    Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles .
    Lipid 29
  • HY-134782

    Liposome Others
    OF-Deg-Lin is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    OF-Deg-Lin
  • HY-159735

    Liposome Others
    Lipid 23 is an ionizable cationic amino lipid that can be used to generate lipid nanoparticles (LNP). Lipid 23 can be used for mRNA delivery .
    Lipid 23
  • HY-153376

    Liposome Others
    LNP Lipid-6 (Compound Lipid 5) is an ionizable lipid (amino lipid). LNP Lipid-6 can be used to prepare lipid nanoparticles (LNP) .
    LNP Lipid-6
  • HY-153375

    Liposome Others
    LNP Lipid-5 (Compound Lipid 2) is an ionizable lipid (amino lipid). LNP Lipid-5 can be used to prepare lipid nanoparticles (LNP) .
    LNP Lipid-5
  • HY-159725

    Liposome Others
    BAmP-O16B is an ionizable cationic amino lipid that can be used to generate lipid nanoparticles (LNPs) .
    BAmP-O16B
  • HY-171113

    Liposome Cancer
    CP-LC-1143 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA).
    CP-LC-1074
  • HY-172017

    Liposome Cancer
    CP-LC-1254 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-1254
  • HY-172014

    Liposome Cancer
    CP-LC-0743 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-0743
  • HY-172016

    Liposome Cancer
    CP-LC-0867 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-0867
  • HY-172015

    Liposome Cancer
    CP-LC-1143 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-1143
  • HY-172018

    Liposome Cancer
    CP-LC-0729 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-0729
  • HY-158861

    G1-nPr-C14E

    Liposome Others
    C3-K2-E14 is a multi-ionizable amino-lipid featuring a central tertiary amine with two identical branches and an n-propyl group. Each branch features a propanamide linking to a branched amine, each with two C14 arms and a hydroxyl. Ionizable lipids such as this may be applied in the development of lipid nanoparticles for drug discovery.
    C3-K2-E14
  • HY-153377

    Liposome SARS-CoV Bacterial Infection Inflammation/Immunology
    Lipid 14 is an ionizable amino lipid. Lipid 14 delivers mRNA into target cells, significantly enhancing the in vivo expression efficiency and immunogenicity of mRNA. Lipid 14 can be used to synthesize lipid nanoparticles (LNPs). Lipid 14 can be used for studies of SARS-CoV-2 and Yersinia pestis .
    Lipid 14
  • HY-159860

    Liposome Others
    IR-117-17 is an ionizable cationic amino lipid, targeting the conducting airways. IR-117-17 could be degraded via esterase cleavage and thus be unlikely to accumulate upon repeated dosing .
    IR-117-17
  • HY-176027

    Liposome Others
    CP-LC-1422 is a homocysteine-derived ionizable amino lipid with high RNA delivery capability and can mediate high-level protein expression in vivo. CP-LC-1422 exhibits significant spleen targeting via intravenous injection in a lipid nanoparticle (LNP) formulation with no significant toxicity observed .
    CP-LC-1422
  • HY-142977

    Liposome Drug Intermediate Others
    6-Oxohexyl 2-hexyldecanoate, 80% (ELSD) is an intermediate in the synthesis of ALC-0315. ALC-0315 is an ionizable amino lipid. ALC-0315 is a key component of LNP delivery vehicles. 6-Oxohexyl 2-hexyldecanoate, 80% (ELSD) is an effective delivery vehicle of mRNA .
    6-Oxohexyl 2-hexyldecanoate, 80% (ELSD)
  • HY-145799
    5A2-SC8
    1 Publications Verification

    Liposome Cancer
    5A2-SC8 is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
    5A2-SC8
  • HY-145799A
    5A2-SC8 TFA
    1 Publications Verification

    Liposome Cancer
    5A2-SC8 TFA is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 TFA LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
    5A2-SC8 TFA

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: